'Troponin t' diaporamas de présentation

Troponin t - PowerPoint PPT Presentation

ACUTE CHEST PAIN NEW APPROACHES TO AN OLD PROBLEM

ACUTE CHEST PAIN NEW APPROACHES TO AN OLD PROBLEM

ACUTE CHEST PAIN NEW APPROACHES TO AN OLD PROBLEM. Peter J. Paganussi MD, FACEP Assistant Clinical Professor Georgetown University School of Medicine Staff Physician / Department of Emergency Medicine INOVA Fairfax Hospital. Total # of Patients - 5400.

★ ★ ★ ★ ★

640 views • 62 slides
Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy

Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy

Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy. John F. Robb, MD Associate Professor of Medicine Director, Cardiac Catheterization Laboratories. December 6, 2004. Alcohol Septal Ablation. Case Presentation The patient is a 61 year old female History of lifelong murmur

★ ★ ★ ★ ★

842 views • 44 slides
Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy

Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy

Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy. John F. Robb, MD Associate Professor of Medicine Director, Cardiac Catheterization Laboratories. December 6, 2004. Alcohol Septal Ablation. Case Presentation The patient is a 61 year old female History of lifelong murmur

★ ★ ★ ★ ★

934 views • 44 slides
Cardiorespiratory assessment

Cardiorespiratory assessment

Cardiorespiratory assessment. Plan. Overview of respiratory and cardiovascular assessment to give you a framework on which to base your assessment process when out on clinical placement for the self ventilating adult patient Handout on StudyNet Please read around in the textbooks.

★ ★ ★ ★ ★

7.21k views • 33 slides
The Safety and Tolerability of Atopaxar (E5555) in the Treatment of Patients with Acute Coronary Syndromes: The LANCE

The Safety and Tolerability of Atopaxar (E5555) in the Treatment of Patients with Acute Coronary Syndromes: The LANCE

The Safety and Tolerability of Atopaxar (E5555) in the Treatment of Patients with Acute Coronary Syndromes: The LANCELOT-ACS Trial.

★ ★ ★ ★ ★

583 views • 22 slides
Cardiac Markers

Cardiac Markers

Cardiac Markers. byN.X. Cardiac Markers. 1. After the loss of integrity of cardiac myocyte membranes, intracellular macromolecules diffuse into the interstitium lymphatics, and microvasculature. 2. CK, CK isoforms, troponins, and myoglobin. Creatine Kinases.

★ ★ ★ ★ ★

858 views • 19 slides
Initial energy setting, outcome and efficacy in direct current cardioversion of atrial fibrillation and flutter

Initial energy setting, outcome and efficacy in direct current cardioversion of atrial fibrillation and flutter

Initial energy setting, outcome and efficacy in direct current cardioversion of atrial fibrillation and flutter. The probability of success on the first shock in AF of > 30 days duration was 5.5% at < 200 J, 35% at 200 J and 56% at 360J In atrial flutter, an initial 100 J shock work in 68%

★ ★ ★ ★ ★

277 views • 11 slides

View Troponin t PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Troponin t PowerPoint presentations. You can view or download Troponin t presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.